Perspective Therapeutics Inc’s Mixed Bag: Up 123.05% in 6 Months, Up 75.10% in 30 Days

Perspective Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $1.00 on 02/07/24, while the lowest price during the same period was $0.20 on 09/15/23.

52-week price history of CATX Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Perspective Therapeutics Inc’s current trading price is -10.00% away from its 52-week high, while its distance from the 52-week low is 339.02%. The stock’s price range during this period has fluctuated between $0.20 and $1.00. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.21 million for the day, which was evidently lower than the average daily volume of 1.8 million over the last three months.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Financial Performance and Market Capitalization

Perspective Therapeutics Inc (CATX) has experienced a quarterly rise of 252.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 443.98M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4414, with a change in price of +0.6300. Similarly, Perspective Therapeutics Inc recorded 1,241,464 in trading volume during the last 100 days, posting a change of +233.33%.

CATX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CATX stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.

CATX Stock Stochastic Average

The raw stochastic average for Perspective Therapeutics Inc over the last 50 days is presently at 87.05%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 72.86%. Further, the company’s Stochastic %K and %D values for the last 20 days were 84.99% and 87.18%, respectively.

CATX Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded an increase of 123.88%. However, over the last six months, the performance has been weaker by 123.05%. The price of CATX increased 75.10% over the last 30 days. And in the last five days, it has surged by 2.54%.

On Key

Related Posts